Academic Journal
Προβολή σε EDS

Genomic profiling of Morganella morganii: insights into antibiotic resistance genes, pathogenicity islands, and toxin-antitoxin systems.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Genomic profiling of Morganella morganii: insights into antibiotic resistance genes, pathogenicity islands, and toxin-antitoxin systems.
Συγγραφείς: Senbadejo TY; West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), Department of Biochemistry, University of Ghana, Accra, Ghana., Bourne CR; Department of Chemistry and Biochemistry, University of Oklahoma, Norman, Oklahoma, USA., Isawumi A; West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), Department of Biochemistry, University of Ghana, Accra, Ghana.; Antimicrobial Resistance Research Group, West African Centre for Cell Biology of Infectious Pathogens, College of Basic and Applied Science, University of Ghana, Legon Accra, Ghana.
Πηγή: Microbiology spectrum [Microbiol Spectr] 2026 Jun 02; Vol. 14 (6), pp. e0220725. Date of Electronic Publication: 2026 May 12.
Τύπος έκδοσης: Journal Article
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: ASM Press Country of Publication: United States NLM ID: 101634614 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2165-0497 (Electronic) Linking ISSN: 21650497 NLM ISO Abbreviation: Microbiol Spectr Subsets: MEDLINE
Imprint Name(s): Original Publication: Washington, DC : ASM Press, 2013-
Ιατρικοί όροι (MeSH): Morganella morganii*/genetics , Morganella morganii*/drug effects , Morganella morganii*/pathogenicity , Morganella morganii*/isolation & purification , Toxin-Antitoxin Systems*/genetics , Genomic Islands*/genetics , Drug Resistance, Multiple, Bacterial*/genetics, Anti-Bacterial Agents/pharmacology ; Virulence Factors/genetics ; Enterobacteriaceae Infections/microbiology ; Plasmids/genetics ; Bacterial Proteins/genetics ; Bacterial Proteins/metabolism ; Drug Resistance, Bacterial/genetics ; Humans ; Animals ; Genome, Bacterial ; Interspersed Repetitive Sequences ; Genomics
Περίληψη: Morganella morganii is an opportunistic pathogen affecting immunocompromised and hospitalized intensive care patients. It colonizes diverse environments and exhibits multidrug resistance. Its genome encodes factors that impart pathogenicity and resistance to multiple antibiotics. This study provided insights into the resistome, mobilome, and toxin-antitoxin systems of M. morganii strains from human clinical samples, food, animals, and wastewater. The pangenome predicted 2,852 core genes shared by >99% of the strains, with >30% of coding sequences annotated as hypothetical proteins co-localizing with virulence factors on mobile genetic elements (MGEs). M. morganii carried 1-3 plasmids and up to 71 diverse MGEs, independent of strain source. The strains shared unique 13-33 GI clusters (10-167 kb) in chromosomes and plasmids harboring transposable elements, phage-associated proteins, toxin-antitoxins (TAs), and additional virulence determinants. Diverse antimicrobial resistance genes, including aac(3)-lld, blaKPC, and blaNDM, were identified. A total of 24 distinct TA families were identified, predominantly belonging to the type II group, and three were identified as types IV and VII. The hha-tomB, higBA, mazEF, vapBC, and doc-phd TAs were the most prevalent, typically occurring as a single copy (hha-tomB) or multiple copies (higBA) in all strains. Although the presence or absence of plasmid and other mobile genetic elements influences the number of resistance genes, it has less of an effect on toxin-antitoxin system distribution. These findings emphasize the significance of MGEs in the evolution and propagation of antimicrobial resistance genes and virulence factors within M. morganii, highlighting their contribution to bacterial adaptation and survival in hostile environments.IMPORTANCEMorganella morganii, an emerging opportunistic pathogen, has garnered increasing attention in recent years due to its role in nosocomial infections and rising antimicrobial resistance (AMR). This study provides a comprehensive genomic analysis of M. morganii strains from diverse sources, revealing how mobile genetic elements (MGEs) drive the spread of AMR genes and virulence factors. By mapping the resistome, mobilome, and toxin-antitoxin (TA) systems across the pangenome, we uncover the conserved and variable genomic features that enable M. morganii to thrive in clinical and environmental niches. Our findings offer novel insights into the potential genomic determinants of persistence, adaptation, and multidrug resistance in an understudied and emerging opportunistic pathogen, informing surveillance strategies and the development of targeted interventions. This study shows that M. morganii encodes chromosomal and mobile genetic element-mediated virulence factors. Resistance and virulence determinants in M. morganii are comparable to those of other known pathogenic bacteria; hence, they should be given significant research attention.
Competing Interests: The authors declare no conflict of interest.
References: J Antimicrob Chemother. 2017 May 1;72(5):1320-1326. (PMID: 28119479)
Front Microbiol. 2022 Jan 12;12:815911. (PMID: 35095819)
Microorganisms. 2023 Feb 17;11(2):. (PMID: 36838480)
Nat Rev Microbiol. 2011 Sep 19;9(11):779-90. (PMID: 21927020)
Cureus. 2023 Sep 20;15(9):e45600. (PMID: 37868540)
Mol Cell. 2018 Jun 7;70(5):768-784. (PMID: 29398446)
Nat Microbiol. 2022 Jul;7(7):1028-1040. (PMID: 35725776)
mSystems. 2024 Jul 23;9(7):e0030624. (PMID: 38884495)
Sci Rep. 2017 Apr 07;7:46157. (PMID: 28387353)
Nat Chem Biol. 2025 Feb;21(2):182-192. (PMID: 38834893)
BMC Microbiol. 2021 Feb 19;21(1):55. (PMID: 33602143)
Genes (Basel). 2023 Jun 16;14(6):. (PMID: 37372459)
Sci Rep. 2016 Aug 31;6:32285. (PMID: 27576575)
Nucleic Acids Res. 2023 Jan 6;51(D1):D690-D699. (PMID: 36263822)
Sci Rep. 2016 Dec 02;6:38204. (PMID: 27910884)
PLoS Pathog. 2019 Jul 19;15(7):e1007885. (PMID: 31323074)
Front Cell Infect Microbiol. 2019 May 22;9:167. (PMID: 31231616)
Nucleic Acids Res. 2018 Jan 4;46(D1):D749-D753. (PMID: 29106666)
PeerJ. 2020 Aug 26;8:e9643. (PMID: 32913672)
J Clin Lab Anal. 2022 May;36(5):e24399. (PMID: 35349730)
Nucleic Acids Res. 2024 Jan 5;52(D1):D784-D790. (PMID: 37897352)
Nucleic Acids Res. 2023 Jul 5;51(W1):W484-W492. (PMID: 37140037)
PLoS One. 2025 Jan 23;20(1):e0313141. (PMID: 39847570)
Front Microbiol. 2022 Mar 21;13:858857. (PMID: 35387082)
BMC Genomics. 2012;13 Suppl 7:S4. (PMID: 23282187)
Front Cell Infect Microbiol. 2025 Jan 31;14:1464736. (PMID: 39958990)
Philos Trans R Soc Lond B Biol Sci. 2022 Jan 17;377(1842):20200460. (PMID: 34839706)
Curr Opin Microbiol. 2023 Jun;73:102293. (PMID: 36958122)
J Antimicrob Chemother. 2018 Jun 1;73(6):1530-1536. (PMID: 29566147)
Microb Genom. 2021 Nov;7(11):. (PMID: 34739369)
J Antimicrob Chemother. 2021 Jan 1;76(1):101-109. (PMID: 33009809)
Res Microbiol. 2025 Sep-Oct;176(7):104303. (PMID: 40582582)
Mol Cell. 2020 Jul 16;79(2):280-292.e8. (PMID: 32533919)
Proteomics. 2023 Dec;23(23-24):e2200421. (PMID: 37609810)
Infect Immun. 2019 Dec 17;88(1):. (PMID: 31611275)
Int J Mol Sci. 2024 Nov 13;25(22):. (PMID: 39596231)
Toxins (Basel). 2023 Feb 17;15(2):. (PMID: 36828478)
Pathogens. 2023 Feb 02;12(2):. (PMID: 36839512)
Mini Rev Med Chem. 2022;22(20):2608-2623. (PMID: 35422211)
J Bacteriol. 2009 Feb;191(4):1258-67. (PMID: 19060153)
Toxins (Basel). 2016 Oct 22;8(10):. (PMID: 27782085)
Nucleic Acids Res. 2024 Jul 5;52(W1):W78-W82. (PMID: 38613393)
J Antimicrob Chemother. 2020 Dec 1;75(12):3491-3500. (PMID: 32780112)
Nucleic Acids Res. 2014 Apr;42(7):4590-605. (PMID: 24465005)
Nucleic Acids Res. 2020 May 7;48(8):4357-4370. (PMID: 32232417)
Clin Microbiol Rev. 2018 Aug 1;31(4):. (PMID: 30068738)
Biochem Biophys Res Commun. 2010 Jan 1;391(1):209-13. (PMID: 19909729)
Sci Rep. 2019 Jul 8;9(1):9872. (PMID: 31285520)
Front Microbiol. 2021 Sep 28;12:744291. (PMID: 34650543)
Bioinformatics. 2006 Sep 15;22(18):2196-203. (PMID: 16837528)
Microbiol Spectr. 2022 Jun 29;10(3):e0056922. (PMID: 35467403)
Front Cell Infect Microbiol. 2021 May 18;11:661026. (PMID: 34084755)
Curr Res Microb Sci. 2021 Jul 07;2:100047. (PMID: 34841338)
Microbiol Spectr. 2022 Jun 29;10(3):e0026522. (PMID: 35510850)
Front Genet. 2018 Dec 12;9:619. (PMID: 30631340)
Nat Chem Biol. 2016 Apr;12(4):208-14. (PMID: 26991085)
PLoS One. 2022 Oct 13;17(10):e0276085. (PMID: 36228026)
Gut Microbes. 2021 Jan-Dec;13(1):1992237. (PMID: 34711138)
PLoS Genet. 2017 Sep 20;13(9):e1007007. (PMID: 28931012)
Lett Appl Microbiol. 2020 Jan;70(1):21-28. (PMID: 31630429)
J Am Geriatr Soc. 2002 Jul;50(7 Suppl):S230-5. (PMID: 12121518)
Nucleic Acids Res. 2015 Jan;43(Database issue):D624-30. (PMID: 25336619)
Mol Biol Evol. 2020 May 1;37(5):1530-1534. (PMID: 32011700)
Int J Infect Dis. 2016 Sep;50:10-7. (PMID: 27421818)
Microb Genom. 2022 May;8(5):. (PMID: 35584003)
Cell Biol Toxicol. 2022 Feb;38(1):111-127. (PMID: 33651227)
mSphere. 2017 Apr 19;2(2):. (PMID: 28435889)
mBio. 2025 Apr 9;16(4):e0025825. (PMID: 39998207)
Nat Chem Biol. 2011 Jun;7(6):359-66. (PMID: 21516113)
J Infect Public Health. 2024 Mar;17(3):430-434. (PMID: 38262080)
Mol Cell. 2021 Aug 5;81(15):3160-3170.e9. (PMID: 34174184)
Sci Rep. 2018 Jul 6;8(1):10292. (PMID: 29980701)
Vet Sci. 2022 Oct 12;9(10):. (PMID: 36288175)
mSphere. 2021 Jun 30;6(3):e0042421. (PMID: 34077263)
mBio. 2017 May 30;8(3):. (PMID: 28559487)
Genome Biol. 2020 Jul 22;21(1):180. (PMID: 32698896)
J Antimicrob Chemother. 2020 Apr 1;75(4):903-906. (PMID: 31971235)
Curr Microbiol. 2025 Feb 15;82(4):137. (PMID: 39955358)
PLoS Pathog. 2024 Apr 19;20(4):e1012169. (PMID: 38640137)
FEMS Microbiol Lett. 2014 Oct;359(2):166-72. (PMID: 25168469)
Lancet Microbe. 2024 Jun;5(6):e547-e558. (PMID: 38677305)
mBio. 2018 Jun 12;9(3):. (PMID: 29895634)
FEMS Microbiol Rev. 2017 May 1;41(3):343-353. (PMID: 28449040)
Infect Immun. 2022 Jul 21;90(7):e0003522. (PMID: 35695502)
Biosci Biotechnol Biochem. 2017 May;81(5):854-862. (PMID: 28077029)
J Bacteriol. 2004 May;186(10):3086-96. (PMID: 15126470)
Clin Microbiol Rev. 2004 Jan;17(1):14-56. (PMID: 14726454)
Contributed Indexing: Keywords: Morganella morganii; antimicrobial resistance; defense systems; pathogenicity islands; toxin-antitoxins; virulence
Substance Nomenclature: 0 (Anti-Bacterial Agents)
0 (Virulence Factors)
0 (Bacterial Proteins)
Entry Date(s): Date Created: 20260512 Date Completed: 20260603 Latest Revision: 20260813
Update Code: 20260813
PubMed Central ID: PMC13227991
DOI: 10.1128/spectrum.02207-25
PMID: 42117717
Βάση Δεδομένων: MEDLINE
Περιγραφή
ISSN:2165-0497
DOI:10.1128/spectrum.02207-25